First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784

Mise à jour : Il y a 4 ans
Référence : NCT02212080

Femme Homme

  • | Pays :
  • Germany
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study is a first in human study that will investigate the safety, tolerability and pharmacokinetics of ascending single doses of BAY1214784 using a placebo controlled, randomized, single center design. In addition the bioavailability of two different liquid formulations will be compared.


Critère d'inclusion

  • Clinical Trials, Phase I as Topic

Liens